About
Our Story
Our People
Careers
Science
Our Science
Pipeline
Izokibep
Lonigutamab
XLRN-517
Community
Patients
Partnerships
Investors
For Investors
Press Releases
Events
News Center
News Center
Media Kit
Contact
News Center
All
Company News
Press Releases
Events
Resources
Presentations
Data from Global Phase 2 Trial of Izokibep in Patients with Psoriatic Arthritis
Presentation
Data from Global Phase 2 Trial of Izokibep in Patients with Psoriatic Arthritis
View Presentation
Achievement of Different Treatment Targets with Izokibep Demonstrates Efficacy Benefits
Presentation
Achievement of Different Treatment Targets with Izokibep Demonstrates Efficacy Benefits
View Presentation